Nationwide Mortality Trends from 2001 to 2020 in Greece: Health Policy Implications under the Scope of Aging Societies
Maria Nikolaou,Nikolaos Theodorakis,Georgios Feretzakis,Georgia Vamvakou,Christos Hitas,Sofia Kalantzi,Aikaterini Spyridaki,Anastasios Apostolos,Vassilios S Verykios,Konstantinos Toutouzas
DOI: https://doi.org/10.1016/j.hjc.2024.08.009
2024-08-28
Abstract:Introduction: This nationwide study aims to analyze mortality trends for all individual causes in Greece from 2001 to 2020, with a specific focus on 2020 - a year influenced by the coronavirus pandemic. As Greece is the fastest-aging country in Europe, the study's findings can be generalized guiding the re-evaluation of global health policies. Methods: Data on the population and the number of deaths were retrieved from the Hellenic Statistical Authority. We calculated age-standardized mortality rates (ASMR) and cause-specific mortality rates by gender in three age groups (0-64, 65-79, and 80+) from 2001 to 2020. Proportional mortalities for 2020 were determined. Statistical analysis used generalized linear models with Python Programming Language. Results: From 2001 to 2020, cardiovascular diseases (CVD) ASMR decreased by 42,7% (p<0,0001), with declines in most sub-causes, except for hypertensive diseases, which increased by 2,8-fold (p<0,0001). In 2020, the proportional mortalities of the three leading causes were 34,9% for CVD, 23,5% for neoplasms, and 9,6% for respiratory diseases (RD). In 2020, CVD dominate in ages 80+ (39,3%), while neoplasms prevail in ages 0-79 (37,7%). Among cardiovascular sub-causes, cerebrovascular diseases dominate in ages 80+ (30,3%), while ischemic heart diseases prevail in ages 0-79 (up to 60,0%). Conclusions: The global phenomenon of population aging necessitates a re-framing of health policies in our aging societies, focusing on diseases with either a high mortality burden, such as CVD, neoplasms, and RD, or those experiencing increasing trends, such as hypertensive diseases.